Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation

Liver Transplantation

Volumn 18, Issue 2, 2012, Pages 166-176

  Friedman, Benjamin H ^a,c   Wolf, Joshua H ^a,c   Wang, Liqing ^c   Putt, Mary E ^b   Shaked, Abraham ^a   Christie, Jason D ^b   Hancock, Wayne W ^c   Olthoff, Kim M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIVER TRANSPLANTATION; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHILADELPHIA; PREDICTIVE VALUE OF TESTS; REPERFUSION INJURY; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863011924     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22451     Document Type: Article

References (31)

1. Deschênes M, Belle SH, Krom RA, Zetterman RK, Lake JR,. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 1998; 66: 302-310.
2. Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 2010; 16: 943-949.
3. Rosen HR, Martin P, Goss J, Donovan J, Melinek J, Rudich S, et al. Significance of early aminotransferase elevation after liver transplantation. Transplantation 1998; 65: 68-72. (Pubitemid 28100433)
4. Totsuka E, Fung JJ, Hakamada K, Ohashi M, Takahashi K, Nakai M, et al. Synergistic effect of cold and warm ischemia time on postoperative graft function and outcome in human liver transplantation. Transplant Proc 2004; 36: 1955-1958. (Pubitemid 39429467)
5. Briceño J, Ciria R,. Early graft dysfunction after liver transplantation. Transplant Proc 2010; 42: 631-633.
6. Busuttil RW, Tanaka K,. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651-663. (Pubitemid 36874450)
7. Hassan L, Bueno P, Ferrõn-Celma I, Ramia JM, Garrote D, Muffak K, et al. Early postoperative response of cytokines in liver transplant recipients. Transplant Proc 2006; 38: 2488-2491. (Pubitemid 44711958)
8. Tilg H, Vogel W, Aulitzky WE, Herold M, Königsrainer A, Margreiter R, Huber C,. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation. Transplantation 1990; 49: 1074-1080. (Pubitemid 20227630)
9. Miki C, McMaster P, Mayer AD, Iriyama K, Suzuki H, Buckels JA,. Factors predicting perioperative cytokine response in patients undergoing liver transplantation. Crit Care Med 2000; 28: 351-354. (Pubitemid 30120871)
10. Hoffman SA, Wang L, Shah CV, Ahya VN, Pochettino A, Olthoff K, et al.; for Lung Transplant Outcomes Group. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant 2009; 9: 389-396.
11. Breiman L,. Random forests. Mach Learn 2001; 45: 5-32. (Pubitemid 32933532)
12. Harrell FE Jr,. Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer; 2001.
13. Dinarello CA,. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-2147. (Pubitemid 26086851)
14. Camargo CA Jr, Madden JF, Gao W, Selvan RS, Clavien PA,. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26: 1513-1520. (Pubitemid 27520017)
15. Teoh N, Field J, Farrell G,. Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice. J Hepatol 2006; 45: 20-27. (Pubitemid 43850619)
16. Sun Z, Klein AS, Radaeva S, Hong F, El-Assal O, Pan HN, et al. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 2003; 125: 202-215. (Pubitemid 36799120)
17. Hancock WW, Wang L, Ye Q, Han R, Lee I,. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 2003; 15: 479-486. (Pubitemid 37130185)
18. Hancock WW,. Chemokine receptor-dependent alloresponses. Immunol Rev 2003; 196: 37-50. (Pubitemid 37468102)
19. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF,. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100: 279-289. (Pubitemid 27349074)
20. Zhai Y, Shen XD, Hancock WW, Gao F, Qiao B, Lassman C, et al. CXCR3+CD4+ T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury. J Immunol 2006; 176: 6313-6322.
21. Shen X, Wang Y, Gao F, Ren F, Busuttil RW, Kupiec-Weglinski JW, Zhai Y,. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Hepatology 2009; 50: 1537-1546.
22. Xie JF, Wang G, Debonera F, Han R, Dorf ME, Hancock W, Olthoff KM,. Selective neutralization of the chemokine TCA3 reduces the increased injury of partial versus whole liver transplants induced by cold preservation. Transplantation 2006; 82: 1501-1509. (Pubitemid 44967634)
23. Serracino-Inglott F, Habib NA, Mathie RT,. Hepatic ischemia-reperfusion injury. Am J Surg 2001; 181: 160-166. (Pubitemid 32406311)
24. Sun B, Karin M,. NF-κB signaling, liver disease and hepatoprotective agents. Oncogene 2008; 27: 6228-6244.
25. Uchida Y, Ke B, Freitas MC, Yagita H, Akiba H, Busuttil RW, et al. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology 2010; 139: 2195-2206.
26. Zamara E, Galastri S, Aleffi S, Petrai I, Aragno M, Mastrocola R, et al. Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice. J Hepatol 2007; 46: 230-238. (Pubitemid 46001473)
27. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D,. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 1265-1272. (Pubitemid 23183235)
28. Mawet E, Shiratori Y, Hikiba Y, Takada H, Yoshida H, Okano K, et al. Cytokine-induced neutrophil chemoattractant release from hepatocytes is modulated by Kupffer cells. Hepatology 1996; 23: 353-358. (Pubitemid 26045955)
29. Chosay JG, Essani NA, Dunn CJ, Jaeschke H,. Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol 1997; 272 (pt 1): G1195-G1200.
30. Jaeschke H, Smith CW,. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 1997; 61: 647-653. (Pubitemid 27276056)
31. Strey CW, Marquez-Pinilla RM, Markiewski MM, Siegmund B, Oppermann E, Lambris JD, Bechstein WO,. Early post-operative measurement of cytokine plasma levels combined with pre-operative bilirubin levels identify high-risk patients after liver resection. Int J Mol Med 2011; 27: 447-454.